Jynneos Generic Name & Formulations
Smallpox and Monkeypox vaccine, live, non-replicating; contains 0.5–3.95×108 infectious units of MVA-BN live virus; per 0.5mL dose; susp for SC inj; preservative-free.
Prevention of smallpox and monkeypox disease in adults determined to be at high risk for smallpox or monkeypox infection.
Jynneos Dosage and Administration
Give by SC inj (preferably into deltoid). ≥18yrs: 2 doses (0.5mL each) given 4 weeks apart.
<18yrs: not established.
Jynneos Boxed Warnings
Have appropriate medical treatment available to manage possible anaphylactic reactions. Immunocompromised. Vaccination may not protect all recipients. Pregnancy. Nursing mothers.
Jynneos Adverse Reactions
Inj site reactions (eg, pain, swelling, redness, induration, itching), muscle pain, headache, fatigue, nausea, chills; severe allergic reactions.
Jynneos Clinical Trials
Jynneos Patient Counseling